{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alpha glucosidase enzyme", "Antidiabetic agents", "Diabetes mellitus", "Dipeptidyl peptidase-4 enzyme", "Natural products", "SGLT2", "Structure-activity relationship"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30738330", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bioorg.2019.02.009", "S0045-2068(18)31041-1"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "86", "PubDate": {"Year": "2019", "Month": "May"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, \u03b1-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).", "Pagination": {"StartPage": "305", "EndPage": "315", "MedlinePgn": "305-315"}, "Abstract": {"AbstractText": ["Diabetes mellitus is a chronic metabolic disorder which is rapidly spreading worldwide. It is characterized by persistent elevated blood glucose level above normal values (hyperglycemia) due to defect in either insulin secretion or in insulin action or both of them. Currently approved oral synthetic antidiabetic drugs such as biguanides, thiazolidinediones, sulfonylureas, and meglitinides have shown undesirable side effects. Therefore, newer approaches and targets for the management of diabetes mellitus are highly desirable. Dipeptidyl peptidase-4 enzyme, \u03b1-glucosidase enzyme and sodium-dependent glucose co-transporter 2 (SGLT2) have been recognized as effective therapeutic targets for the management of diabetes mellitus while natural products are alternatives to oral synthetic hypoglycemic agents. During the last two decades, many researchers were working on the identification and the validation of plant-derived products for curing various diseases. Natural products do not only provide useful drugs in their own right but also provide templates for the development of more effective compounds for enhanced therapeutic potential. Herein, we advocated the vital role of natural products as source of new drugs by presenting promising inhibitors of dipeptidyle peptidase-4 enzyme, \u03b1-glucosidase enzyme and (SGLT2) obtained from different medicinal plants as potential candidates for drug development against diabetes mellitus. The structure-activity relationship (SAR) of these various inhibitors is also discussed."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e0 degli Studi di Firenze, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino (Florence), Italy; Department of Biological Sciences and Chemistry, University of Nizwa, Birkat Al-Mauz, P.O.Box 33, Nizwa 616, Oman; Natural and Medical Sciences Research Center, University of Nizwa, PC 616, Nizwa, Oman. Electronic address: abbashej@unizwa.edu.om."}], "LastName": "Abbas", "ForeName": "Ghulam", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, PC 616, Nizwa, Oman."}], "LastName": "Al Harrasi", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, PC 616, Nizwa, Oman; Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, D-06120 Halle, (Salle), Germany."}], "LastName": "Hussain", "ForeName": "Hidayat", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences and Chemistry, University of Nizwa, Birkat Al-Mauz, P.O.Box 33, Nizwa 616, Oman."}], "LastName": "Hamaed", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universit\u00e0 degli Studi di Firenze, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino (Florence), Italy. Electronic address: claudiu.supuran@unifi.it."}], "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "SLC5A2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Serine Proteinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Sodium-Glucose Transporter 2"}, {"RegistryNumber": "EC 3.2.1.20", "NameOfSubstance": "alpha-Glucosidases"}, {"RegistryNumber": "EC 3.4.14.5", "NameOfSubstance": "DPP4 protein, human"}, {"RegistryNumber": "EC 3.4.14.5", "NameOfSubstance": "Dipeptidyl Peptidase 4"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dipeptidyl Peptidase 4"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Serine Proteinase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sodium-Glucose Transporter 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Glucosidases"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "9", "Day": "16"}, {"Year": "2019", "Month": "1", "Day": "29"}, {"Year": "2019", "Month": "2", "Day": "3"}, {"Year": "2019", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30738330", "10.1016/j.bioorg.2019.02.009", "S0045-2068(18)31041-1"]}}]}